Loading…
CURX
Curanex Pharmaceuticals Inc
NASDAQ· Healthcare· Biotechnology· CUSIP 23126K106
$4.56-2.56%Price as of Aug 29, 18:48 UTC · updated once a day, after the close
Key metrics
- Market cap
- $7.15M
- P/E
- —
- Forward P/E
- —
- P/B
- 1.4x
- Dividend yield
- —
- Payout
- —
- EPS
- -$7.19
- ROE
- -411.08%
- Profit margin
- 0.00%
- Revenue growth
- —
- Beta
- —
- 52-week high
- $183.60
- 52-week low
- $3.58
History
How the company evolved, year by year. Revenue and debt come from the annual reports — for most companies, the 10-K filings with the SEC since 2009; dividends from the payments themselves.
The bars are a balance on the closing date; the lines are what happened during the year. Revenue above equity is ordinary, not an anomaly — it means the company turns its capital over more than once a year.
Investors holding this
Major managers that reported this stock in their latest 13F.
Price over time
▼ -95.8% over 5Y.
This stock has less than 5 years of price history — the answer would measure a shorter period than the one asked for.
Dividends reinvested, splits accounted for. Past prices say what happened, not what will.
Others in the same sector
Companies of similar size in Healthcare, for comparison. The columns are the same ones above, in the same order.
| Stock | Price | P/E | P/B | Dividend yield | ROE | Market cap |
|---|---|---|---|---|---|---|
| BOLTBolt Biotherapeutics, Inc. | $3.71 | — | 0.6x | — | -111.65% | $7.15M |
| INBSIntelligent Bio Solutions Inc | $2.36 | — | 1.2x | — | -307.69% | $7.14M |
| CANFCan-Fite BioPharma Ltd. | $3.40 | — | 0.8x | — | -178.24% | $7.28M |
| INMInMed Pharmaceuticals Inc. | $1.38 |
About the company
Curanex Pharmaceuticals Inc, a developmental stage pharmaceutical company, discovers, develops, and commercializes botanical drugs to treat patients with inflammatory diseases. It develops Phyto-N for various therapeutic areas, including ulcerative colitis, atopic dermatitis, COVID-19, diabetes, nonalcoholic fatty liver disease, and gout. The company was formerly known as Fordman Pharma Inc. and changed its name to Curanex Pharmaceuticals Inc in November 2023. Curanex Pharmaceuticals Inc was founded in 1996 and is headquartered in Jericho, New York.
- 6
- Jericho, United States
Company description provided by Yahoo Finance.